Psoriasis, RA Linked to Cardiovascular Events: Do Meds Affect the Risk?

Cardiovacular Risks Seen Early On in Schizophrenia
Cardiovacular Risks Seen Early On in Schizophrenia
Patients with psoriasis, psoriatic arthritis (PsA), and rheumatoid arthritis (RA) may be at an increased risk of major adverse cardiovascular events (MACE) depending on their pharmacological treatment, reports new findings.

Objectives: We aimed to quantify the risk of major adverse cardiovascular events (MACE) among patients with psoriatic arthritis (PsA), rheumatoid arthritis (RA) and psoriasis without known PsA compared with the general population after adjusting for traditional cardiovascular risk factors.

READ FULL ARTICLE Curated publisher From Bmj

  • Latest News Your top articles for Friday

  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More